Mark Erlander - Mar 9, 2022 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Chief Executive Officer, Director
Signature
/s/ Mark Erlander
Stock symbol
CRDF
Transactions as of
Mar 9, 2022
Transactions value $
$0
Form type
4
Date filed
3/10/2022, 05:39 PM
Previous filing
Jun 14, 2021
Next filing
Nov 29, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRDF Stock Options Award $0 +370K +45.4% $0.00 1.19M Mar 9, 2022 Common Stock 370K $2.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 92,532 vest on 3/09/2023. 7,711 vest monthly for 36 months beginning on 4/09/2023 through 3/09/2026.